Table 5.

Multivariable logistic regression model with failure of multiple (≥ 2) bDMARD therapies as outcome

Independent variables	Failure of multiple (≥ 2) bDMARD therapies
	Multivariable analysis
	OR (95% CI)	p
Anti-IL17 as first drug	− 1.91 (− 4.06, 0.24)	0.082
Anti-IL12/23 as first drug	− 0.64 (− 2.31, 1.02)	0.447
Female sex	0.69 (0.07, 1.31)	0.030
Age	0.02 (0.01, 0.04)	0.229
bDMARD initiation < 2015	0.09 (0.72, 0.91)	0.060

Significant result is highlighted in bold. p ≤ 0.05

bDMARD biological disease-modifying anti-rheumatic drug, IL interleukin, CI confidence interval